Literature DB >> 24729802

Esophageal stents for less invasive treatment of mediastinitis.

Jarmil Safranek1, Jan Geiger1, Vladimir Vesely1, Josef Vodicka1, Vladislav Treska1.   

Abstract

INTRODUCTION: In spite of the progress in diagnosis and therapeutic options, esophageal perforation resulting in mediastinitis is a very serious condition with a high morbidity. AIM: To evaluate the use of esophageal stents for the treatment of patients suffering from mediastinitis.
MATERIAL AND METHODS: Retrospective (2008-2012) analysis of a group of patients requiring surgical treatment. The evaluation was focused on the cause of perforation, stent type and its parameters, the surgical method used, duration of stenting and total length of treatment.
RESULTS: In total, 16 patients were treated by stenting. All patients were treated with the stent being placed across the defect in the esophagus. Mediastinitis was accessed and drained with the aid of a thoracotomy or thoracolaparotomy (8 cases), or using a combination of a laparotomy/laparostomy and pleural drainage (5 cases). The most basic interventions were either pleural or external cervical drainage (3 and 1 cases, respectively). One patient, in whom a stricture had developed at the healed perforation, was subjected to esophageal resection. Four patients died. The average period that the stent was left in situ was 53.7 days. The average period of hospitalization of those patients who survived was 53.4 days.
CONCLUSIONS: Using stents in therapy neither increased survival (mortality of 25%), nor decreased the length of therapy of patients once mediastinitis had developed. The main advantage of stenting is the preservation of the native esophagus and the reduced extent of surgical mediastinal drainage.

Entities:  

Keywords:  esophageal perforation; esophageal stent; mediastinitis

Year:  2014        PMID: 24729802      PMCID: PMC3983542          DOI: 10.5114/wiitm.2014.40156

Source DB:  PubMed          Journal:  Wideochir Inne Tech Maloinwazyjne        ISSN: 1895-4588            Impact factor:   1.195


Introduction

Anastomosis insufficiency and esophageal perforation often lead rapidly to mediastinitis, in many cases resulting in fatality (mortality of 15–75%). The most frequent cause of this condition in patients is an endoscopic examination (50–75% of reported perforations), and particularly endoscopic interventions [1-4]. Esophageal perforations occurring during the diagnostic esophagogastroscopy (EGDS) are reported with a frequency of about 0.05–0.1% of all EGDS [5]. The next most frequent causes of esophageal perforation and mediastinitis are spontaneous perforation, impacted food bolus, foreign bodies, esophageal corrosion (10%), and trauma (1–3%) [1]. Postoperative complications include anastomotic insufficiency after esophageal resection, perforation during esophagofundoplication and esophageal injury during other thoracic surgery procedures [6].

Aim

To evaluate the use of esophageal stents for the treatment of patients suffering from mediastinitis due to esophageal perforation.

Material and methods

We performed a retrospective analysis of a patient group with mediastinitis caused by an esophageal defect that had been treated by stenting at our department. The analysis covers a period of 5 years (2008–2012). Mediastinitis was diagnosed by endoscopic or esophagram evidence of an esophageal defect and mediastinal collection was identified by computed tomography (CT), which then requires surgical intervention. Patients included in the study group were originally treated at our department or transferred from other hospitals. None of them were subjected to primary surgical treatment outside our department. Each patient was administered broad-spectrum antibiotics and antimycotics. Patients with perforation of a malignant esophageal tumor, not indicated for primary surgical treatment, were excluded from the study. We implanted a stent manufactured by ELLA-CS, Hradec Kralove, Czech Republic. We evaluated the cause of perforation, type of stent and its parameters, the surgical techniques used, the period that the stent was left in situ and the period of hospitalization.

Results

Within the period 2008–2012, 16 patients with mediastinitis following esophageal injury were operated on. Iatrogenic esophageal lesion caused the mediastinitis in 8 patients. Six patients suffered from postoperative perforation (3 of these with anastomotic insufficiency after esophageal resection, 2 with perforation after esophagofundoplication, and 1 patient with perforation after cardiomyotomy) while there were 2 cases of perforation during EGDS. The etiology of esophageal perforation was spontaneous in 4 cases (2 without any obvious pathology, 1 related to hiatal hernia and 1 related to reflux esophagitis). Three cases of perforation were due to an impacted food bolus (meat, trichobezoar) and acid corrosion was the cause in 1 case. After documented evidence of perforation or insufficiency of the esophagus, all patients were treated using surgical drainage and, in addition, by a stent implanted across the defect. The stent was introduced as soon as possible after evidence of perforation was made available, on average after a period of 1.8 days (within the range of 0–9 days) related to the presence of an endoscopy-trained surgeon at the department and the availability of an optimal stent. In 14 cases the stent was implanted under endoscopic control and in 2 cases perioperatively, without endoscopy. The majority of chosen stents had a diameter of 20 mm, with a proximal flare preventing dislocation. The stent is made of nitinol alloy with high corrosion resistance. It is covered by polyurethane foil. The length of the stent was within 100–150 mm. In cases where a custom made biodegradable polydioxanone stent was used, the larger diameter of 25 mm was preferred. The stent length was arranged in cooperation with the manufacturer. The average period that non-biodegradable stents were left in situ in surviving patients was 53.7 days (with a range of 20–95 days). The results with respect to types of stents implanted are presented in the Table I.
Table I

Surgical techniques

Sex, age [years]Etiology of esophageal perforationStent diameter × length [mm]Period from establishing perforation to stentingStenting duration [days]Surgical therapy, mediastinal approachHospital LOS [days]
Male, 51Spontaneous20 × 150The same day56Suture, thoracotomy, laparotomy62 – discharge
Male, 604th day after esophageal resection due to adenocarcinoma20 × 1202 daysLeftLaparotomy + thoracic drainage30 – exitus
Male, 723 days after spontaneous perforation (hiatal hernia)20 × 1501 dayLeftLaparotomy + bilateral thoracic drainage49 – transfer
Female, 46Ahalasia, trichobezoar, psychotic20 × 150The same day95Bilateral thoracic drainage only21 – discharge
Male, 3642nd day after acid corrosion20 × 195 and 20 × 120The same day54Thoracotomy, esophagectomy, laparotomy200 – discharge
Male, 5710th day after cardiomyotomy20 × 1504 days54Laparotomy + bilateral thoracic drainage60 – discharge
Female, 675th day after fundoplication20 × 120 and 20 ×150The same dayLeftThoracotomy61 – exitus
Male, 64Spontaneous20 × 120 and 20 ×1201 day662× thoracotomy147 – exitus
Female, 5514th day after esophageal resection due to adenocarcinoma25 × 115 BD6 daysAbsorbedThoracolaparotomy49 – discharge
Male, 6624th day after esophageal resection due to adenocarcinoma20 × 110 BD9 daysAbsorbedThoracic drainage only79 – discharge
Male, 58Diagnostic EGDS20 × 1202 daysLeftLaparotomy + thoracic and cervical drainage27 – discharge
Female, 65Perforation by food impaction25 × 100 BD1 dayAbsorbedCervical mediastinal drainage only22 – discharge
Male, 701 day after spontaneous perforation (GERD)20 × 120The same dayLeftSuture + fundoplication, thoracolaparotomy + thoracotomy 2×27 – transfer
Female, 471 day after perforation by food impaction20 × 120The same day31Thoracotomy + cervical drainage31 – discharge
Female, 482 days after EGDS introduction of jejunal tube20 × 150The same dayLeftSuture, thoracotomy, laparotomy18 – exitus
Female, 542 days after fundoplication (GERD)20 × 1203 days20Laparotomy14 – discharge

EGDS – esophagogastroduodenoscopy, BD – biodegradable stent, GERD – gastroesophageal reflux disease, LOS – length of stay

Surgical techniques EGDS – esophagogastroduodenoscopy, BD – biodegradable stent, GERD – gastroesophageal reflux disease, LOS – length of stay The surgical approach of thoracotomy, or thoracolaparotomy, was used for draining the mediastinitis in 8 cases. Another 5 cases were drained by using the combination of laparotomy/laparostomy and pleural drainage. Pleural drainage alone was sufficient in 3 cases, external cervical drainage in one case. An acute esophagectomy was not needed in any case. It was, however, performed in one case, but already after the perforation had healed, and because of early stenosis. Four of the patients making up the group died (mortality of 25%). The others were discharged or transferred to other departments.

Discussion

In spite of the progress in diagnosis and therapeutic options, esophageal perforation resulting in mediastinitis is a very serious condition with a high morbidity of about 20% (range of 0–40%) [7-10]. Therapy requires information on the site of perforation demonstrated by an esophagram or endoscopy. If these examinations do not reveal a perforation, it is useful to repeat the esophagram within a couple of hours, or to perform CT with an orally administered contrast agent [11]. In addition, CT contributes to the assessment of the possible extent of mediastinal involvement, revealing the emphysema, exudate and abscess of the mediastinum or pleural cavity. These factors represent the main factor in the choice of surgical techniques or type of surgery. Minnich indicates the period beyond 24 h of the occurrence of the defect as being significant (p = 0.02) in the necessity of surgical intervention [12]. Computed tomography evidence of exudate dissemination through the mediastinal pleura (non-contained perforation, p = 0.04) is also a negative prognostic factor [12]. The treatment of mediastinitis after esophageal perforation follows four main principles: closing the perforation, drainage of the mediastinum, broad-spectrum antibiotics/antimycotics, and adequate nutrition [13]. Primary suture, better in two layers (mucosal and muscular), is recommended for closing, provided the perforation margins are suitable for suture [14]. Reinforcement of the suture with the aid of a muscle flap, pleura, pericard or fundoplication would be advantageous and is recommended [15]. In cases when the period after perforation is longer than 24 h, many authors recommend just the drainage of the adjacent mediastinum and refer to frequent failure of the primary suture [3, 16]. A contradictory view prefers a primary surgical suture regardless of the time elapsed since the injury [17-19]. The decision on the type of treatment required is always made on an individual basis and often results from observations made during the surgery. The need for making a wide surgical access to the area of perforation represents a drawback of the primary suture therapy. The anastomotic insufficiency after esophageal resection precludes the suturing entirely. Stenting makes a significant contribution to current treatment (Photo 1). If we presume healing of the perforation and stent extraction, the stent type and quality of metal it is made of are less important than the need for using the stent with a covering (polyethylene or polyurethane) that should prevent leakage from the stent lumen. The design of the proximal stent flare sufficiently prevents the stent migration that occurs in up to 30% of cases in which other stents are used [20-22]. The recommended period between stent implantation and removal that is considered to be optimal is 1 month (sometimes even 2, max. 3 months). If the healing of the defect does not take place within the chosen implantation period, it is possible to implant a further stent. Stents made of biodegradable material (polydioxanone) are now available and may be applied in situations when the future extraction of the stent is uncertain.
Photo 1

Intraoperatively introduced stent. Stenting was followed by esophageal suture supported by fundoplication

Intraoperatively introduced stent. Stenting was followed by esophageal suture supported by fundoplication A combined procedure consisting of concurrent stenting and suturing of the perforation (Photos 2 and 3), eventually reinforced by a flap formed by soft tissue, seems to be advantageous in cases of “uncertain” primary esophageal suture. We consider the single stent implantation to be better than an immediate esophageal resection. The extent of radical surgical intervention of mediastinitis caused by perforation of the carcinoma depends on the patient's condition and the extent of malignant disease [23, 24]. Drainage of mediastinitis is related to the mediastinal level which is affected. External drainage of the upper mediastinum is possible through a cervical approach by establishing passive or flushing drainage. A majority of cases of distal esophageal perforations require an approach from a thoracotomy or thoracolaparotomy. The perforation of the abdominal part of the esophagus requires an approach from a laparotomy and mediastinal drainage through the diaphragmatic hiatus or by establishing a thoracic drainage.
Photo 2

Endoscopic view after concurrent introduction of the stent and nasogastric tube

Photo 3

Spontaneous perforation of the distal esophagus, the approach from a left-sided thoracolaparotomy (about 24 h after the injury). The margin of the perforation is grasped by Allison forceps

Endoscopic view after concurrent introduction of the stent and nasogastric tube Spontaneous perforation of the distal esophagus, the approach from a left-sided thoracolaparotomy (about 24 h after the injury). The margin of the perforation is grasped by Allison forceps

Conclusions

Performance of the surgical revision of mediastinitis after esophageal perforation depends on the extent of mediastinal involvement demonstrated by CT. The surgery is aimed at closing the defect with sutures, a stent or a combination of both interventions. Nowadays, we use the stent in almost all cases of esophageal perforation. Stenting neither increases survival (mortality of 25%) nor decreases the length of therapy once mediastinitis has developed. It facilitates the preservation of the native esophagus and limits the extent of surgical drainage. However, esophagectomy remains an essential part of the therapeutic spectrum. Its indication is made on a wholly individual basis and depends on the general health condition of the patient and on local surgical findings.
  22 in total

1.  Esophageal perforation in adults: aggressive, conservative treatment lowers morbidity and mortality.

Authors:  Stephen B Vogel; W Robert Rout; Tomas D Martin; Patricia L Abbitt
Journal:  Ann Surg       Date:  2005-06       Impact factor: 12.969

2.  Thirty-four cases of esophageal perforation: the experience of a district general hospital in the UK.

Authors:  E A Griffiths; N Yap; J Poulter; M T Hendrickse; M Khurshid
Journal:  Dis Esophagus       Date:  2009-03-17       Impact factor: 3.429

3.  Thoracic esophageal perforations: a decade of experience.

Authors:  Jeffrey L Port; Michael S Kent; Robert J Korst; Matthew Bacchetta; Nasser K Altorki
Journal:  Ann Thorac Surg       Date:  2003-04       Impact factor: 4.330

4.  Delayed primary repair of intrathoracic esophageal perforation: is it safe?

Authors:  N Wang; A J Razzouk; A Safavi; K Gan; G S Van Arsdell; P M Burton; B L Fandrich; M J Wood; A C Hill; E E Vyhmeister; R Miranda; C Ahn; S R Gundry
Journal:  J Thorac Cardiovasc Surg       Date:  1996-01       Impact factor: 5.209

5.  Nonoperative treatment of 15 benign esophageal perforations with self-expandable covered metal stents.

Authors:  Andreas Fischer; Oliver Thomusch; Stefan Benz; Ernst von Dobschuetz; Peter Baier; Ulrich T Hopt
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

6.  Management of esophageal perforations: the value of aggressive surgical treatment.

Authors:  J David Richardson
Journal:  Am J Surg       Date:  2005-08       Impact factor: 2.565

7.  Reinforced primary repair of thoracic esophageal perforation.

Authors:  C D Wright; D J Mathisen; J C Wain; A C Moncure; A D Hilgenberg; H C Grillo
Journal:  Ann Thorac Surg       Date:  1995-08       Impact factor: 4.330

8.  Esophageal repair following late diagnosis of intrathoracic perforation.

Authors:  H C Grillo; E W Wilkins
Journal:  Ann Thorac Surg       Date:  1975-10       Impact factor: 4.330

9.  Personal management of 57 consecutive patients with esophageal perforation.

Authors:  Narendar Mohan Gupta; Lileswar Kaman
Journal:  Am J Surg       Date:  2004-01       Impact factor: 2.565

10.  Strangulation of the stomach and the transverse colon following laparoscopic esophageal hiatal hernia repair.

Authors:  Jacek Hermann; Tomasz Kościński; Stanisław Malinger; Jacek Szmeja; Michał Monkiewicz; Michał Drews
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2012-06-25       Impact factor: 1.195

View more
  4 in total

Review 1.  Stenting as a palliative method in the management of advanced squamous cell carcinoma of the oesophagus and gastro-oesophageal junction.

Authors:  Janusz Wlodarczyk; Jarosław Kużdżał
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2016-03-31       Impact factor: 1.195

2.  Results of endoscopic and surgical fistula treatment in oesophagointestinal anastomosis after gastrectomy.

Authors:  Tomasz Miłek; Piotr Ciostek; Robert Petryka; Jakub Słowik; Mirosław Jarosz
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-12-15       Impact factor: 1.195

3.  Endoscopic treatment of gastric varices bleeding with the use of n-butyl-2 cyanoacrylate.

Authors:  Sławomir Kozieł; Konrad Kobryń; Rafał Paluszkiewicz; Marek Krawczyk; Tadeusz Wróblewski
Journal:  Prz Gastroenterol       Date:  2015-12-16

4.  Endoscopic vacuum-assisted closure system (E-VAC): case report and review of the literature.

Authors:  Maciej Borejsza-Wysocki; Krzysztof Szmyt; Adam Bobkiewicz; Stanisław Malinger; Józef Świrkowicz; Jacek Hermann; Michał Drews; Tomasz Banasiewicz
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-06-08       Impact factor: 1.195

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.